Evidence map›Paper›PMID 26090668›Full record

ArticlePLoS pathogens2015

The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia.

Stephanie M Rangel, Maureen H Diaz, Claire A Knoten, Angelica Zhang, Alan R Hauser

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Characterization of two exoUBMC microbiology · 2026
    Article
  3. Article
  4. Article
  5. Detection of Toxin Genes and Biofilm Formation ofInternational journal of microbiology · 2026
    Article
  6. Comparative Genomic Analysis ofInfection and drug resistance · 2026
    Article
  7. Article
  8. ThemBio · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Anti-Microorganisms · 2023
    Review
  14. Antibiotics (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Neuroinflammation in neurodegenerationFrontiers in immunology · 2022
    Review
  18. VirulentRespiratory medicine case reports · 2022
    Article
  19. Review
  20. Genomic and Metabolic Characteristics of the Pathogenicity inInternational journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephanie M RangelDepartments of Microbiology/Immunology, Feinberg School of Medicine, Northwestern Univesity, Chicago, Illinois, United States of America.
Maureen H DiazDepartments of Microbiology/Immunology, Feinberg School of Medicine, Northwestern Univesity, Chicago, Illinois, United States of America.
Claire A KnotenDepartments of Microbiology/Immunology, Feinberg School of Medicine, Northwestern Univesity, Chicago, Illinois, United States of America.
Angelica ZhangDepartments of Microbiology/Immunology, Feinberg School of Medicine, Northwestern Univesity, Chicago, Illinois, United States of America.
Alan R HauserDepartments of Microbiology/Immunology, Feinberg School of Medicine, Northwestern Univesity, Chicago, Illinois, United States of America; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
Mechanistic Studies of Patatin-like ToxinsR01AI053674 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2003 to 2017
$4.3M
Validating targets in p. aeruginosa type III secretion using chemical probesR01AI099269 · NIAID · MICROBIOTIX, INC · PI MOIR, DONALD T · 2012 to 2015
$3.2M
Pseudomonas aeruginosa Genomic Islands and VirulenceR01AI075191 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2009 to 2013
$1.7M
Patient-Oriented Research on Pseudomonas aeruginosaK24AI104831 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2013 to 2024
$1.2M
Mechanism of Azithromycin Activity in Pseudomonas InfectionsR21AI088286 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HAUSER, ALAN R · 2010 to 2011
$438k
The role of Pseudomonas aeruginosa ExoS during early pneumonia.F31AI089015 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RANGEL, STEPHANIE M · 2010 to 2014
$136k
NCI NIH HHS CA060553NCI NIH HHS P30 CA060553NIAID NIH HHS AI04831NIAID NIH HHS AI053674NIAID NIH HHS AI075191NIAID NIH HHS AI088286NIAID NIH HHS AI089015NIAID NIH HHS AI099269NIAID NIH HHS F31 AI089015NIAID NIH HHS K24 AI104831NIAID NIH HHS R01 AI053674NIAID NIH HHS R01 AI075191NIAID NIH HHS R01 AI099269NIAID NIH HHS R21 AI088286NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

Hospital-acquired pneumonia is associated with high rates of morbidity and mortality, and dissemination to the bloodstream is a recognized risk factor for particularly poor outcomes. Yet the mechanism by which bacteria in the lungs gain access to the bloodstream remains poorly understood. In this study, we used a mouse model of Pseudomonas aeruginosa pneumonia to examine this mechanism. P. aeruginosa uses a type III secretion system to deliver effector proteins such as ExoS directly into the cytosol of eukaryotic cells. ExoS, a bi-functional GTPase activating protein (GAP) and ADP-ribosyltransferase (ADPRT), inhibits phagocytosis during pneumonia but has also been linked to a higher incidence of dissemination to the bloodstream. We used a novel imaging methodology to identify ExoS intoxicated cells during pneumonia and found that ExoS is injected into not only leukocytes but also epithelial cells. Phagocytic cells, primarily neutrophils, were targeted for injection with ExoS early during infection, but type I pneumocytes became increasingly injected at later time points. Interestingly, injection of these pneumocytes did not occur randomly but rather in discrete regions, which we designate ""fields of cell injection" (FOCI). These FOCI increased in size as the infection progressed and contained dead type I pneumocytes. Both of these phenotypes were attenuated in infections caused by bacteria secreting ADPRT-deficient ExoS, indicating that FOCI growth and type I pneumocyte death were dependent on the ADPRT activity of ExoS. During the course of infection, increased FOCI size was associated with enhanced disruption of the pulmonary-vascular barrier and increased bacterial dissemination into the blood, both of which were also dependent on the ADPRT activity of ExoS. We conclude that the ADPRT activity of ExoS acts upon type I pneumocytes to disrupt the pulmonary-vascular barrier during P. aeruginosa pneumonia, leading to bacterial dissemination.

Indexed as

ADP Ribose TransferasesAnimalsBacteremiaBacterial ToxinsDisease Models, AnimalDisease ProgressionFemaleFlow CytometryIatrogenic DiseaseMiceMice, Inbred BALB CPneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsADP Ribose TransferasesBacterial Toxinsexoenzyme S

Identifiers

PMID26090668
PMCPMC4474835
OpenAlexW619004491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.